The emergence of genomic and proteomic biomarkers in heart transplantation

Journal of Heart and Lung Transplantation

Volumn 24, Issue 7 SUPPL., 2005, Pages

  Mehra, Mandeep R ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IMMUNOSUPPRESSIVE AGENT; STEROID; TACROLIMUS;

ALLOIMMUNITY; CARDIAC ALLOGRAFT VASCULOPATHY; CARDIAC GRAFT REJECTION; DNA POLYMORPHISM; GENOMICS; GRAFT FAILURE; HEART MUSCLE BIOPSY; HEART TRANSPLANTATION; HUMAN; INFLAMMATION; MICROVASCULATURE; PRIORITY JOURNAL; PROTEOMICS; REVIEW;

BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; GENOMICS; GRAFT REJECTION; HEART TRANSPLANTATION; HUMANS; INFLAMMATION; PROTEOMICS; TRANSPLANTATION, HOMOLOGOUS;

EID: 21544444993     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2005.04.015     Document Type: Review

References (52)

1. E.R. Garrity Jr, M.R. Mehra An update on clinical outcomes in heart and lung transplantation Transplantation 77 suppl 9 2004 S68 S74
2. H. Valantine Cardiac allograft vasculopathy after heart transplantation risk factors and management J Heart Lung Transplant 23 suppl 5 2004 S187 S193
3. Hauptman P, Mehra MR. It is time to stop ignoring malignancy in heart transplantation: a call to arms. J Heart Lung Transplant (in press).
4. M.R. Mehra, P.A. Uber, W.E. Uber, M.H. Park, R.L. Scott Anything but a biopsy noninvasive monitoring for cardiac allograft rejection Curr Opin Cardiol 17 2002 131 136
5. S.H. Kubo, D.C. Naftel, R.M. Mills Jr Cardiac Transplant Research Database Group Risk factors for late recurrent rejection after heart transplantation a multi-institutional, multivariable analysis J Heart Lung Transplant 14 1995 409 418
6. M.H. Yamani, M. Yousufuddin, R.C. Starling Does acute cellular rejection correlate with cardiac allograft vasculopathy? J Heart Lung Transplant 23 2004 272 276
7. G.L. Winters, B.M. McManus Consistencies and controversies in the application of the International Society for Heart and Lung Transplantation working formulation for heart transplant biopsy specimens. Rapamycin Cardiac Rejection Treatment Trial Pathologists J Heart Lung Transplant 15 1996 728 735
8. G.L. Winters, E. Loh, F.J. Schoen Natural history of focal moderate cardiac allograft rejection. Is treatment warranted? Circulation 91 1995 1975 1980
9. M.C. Fishbein, J. Kobashigawa Biopsy-negative cardiac transplant rejection etiology, diagnosis, and therapy Curr Opin Cardiol 19 2004 166 169
10. C. Chantranuwat, J.H. Qiao, J. Kobashigawa Immunoperoxidase staining for C4d on paraffin-embedded tissue in cardiac allograft endomyocardial biopsies comparison to frozen tissue immunofluorescence Appl Immunohistochem Mol Morphol 12 2004 166 171
11. A.R. Tambur, R.A. Bray, S.K. Takemoto Flow cytometric detection of HLA-specific antibodies as a predictor of heart allograft rejection Transplantation 15 70 2000 1055 1059
12. J.A. Kobashigawa, A. Sabad, D. Drinkwater Pretransplant panel reactive-antibody screens. Are they truly a marker for poor outcome after cardiac transplantation? Circulation 94 suppl 9 1996 II-294 II-297
13. D.O. Taylor, R.L. Yowell, A.G. Kfoury, E.H. Hammond, D.G. Renlund Allograft coronary artery disease clinical correlations with circulating anti-HLA antibodies and the immunohistopathologic pattern of vascular rejection J Heart Lung Transplant 19 2000 518 521
14. J.S. Thompson, L.R. Thacker II, S. Takemoto The influence of conventional and cross-reactive group HLA matching on cardiac transplant outcome an analysis from the United Network of Organ Sharing Scientific Registry Transplantation 69 2000 2178 2186
15. R. John, H. Rajasinghe, J.M. Chen Impact of current management practices on early and late death in more than 500 consecutive cardiac transplant recipients Ann Surg 232 2000 302 311
16. B.K. Shenton, W. Bal, A.E. Bell The value of flow cytometric crossmatch in cardiac transplantation Transplant Int 7 suppl 1 1994 S359 S362
17. J.D. Hosenpud, K.A. Mauck, K.B. Hogan Cardiac allograft vasculopathy IgM antibody responses to donor-specific vascular endothelium Transplantation 63 1997 1602 1606
18. P. Przybylowski, M. Balogna, B. Radovancevic The role of flow cytometry-detected IgG and IgM anti-donor antibodies in cardiac allograft recipients Transplantation 67 1999 258 262
19. S. Itescu, T.C. Tung, E.M. Burke An immunological algorithm to predict risk of high-grade rejection in cardiac transplant recipients Lancet 352 1998 263 270
20. M.R. Mehra, P.A. Uber, H.O. Ventura, R.L. Scott, M.H. Park The impact of mode of donor brain death on cardiac allograft vasculopathy an intravascular ultrasound study JAMA 43 2004 806 810
21. M.H. Yamani, S.A. Haji, R.C. Starling Myocardial ischemic-fibrotic injury after human heart transplantation is associated with increased progression of vasculopathy, decreased cellular rejection and poor long-term outcome JAMA 39 2002 970 977
22. A.B. Taegtmeyer, A.M. Crook, P.J. Barton, N.R. Banner Reduced incidence of hypertension after heterotopic cardiac transplantation compared with orthotopic cardiac transplantation evidence that excision of the native heart contributes to post-transplant hypertension JAMA 44 2004 1254 1260
23. C.A. Labarrere, D.R. Nelson, C.J. Cox Cardiac-specific troponin I levels and risk of coronary artery disease and graft failure following heart transplantation JAMA 284 2000 457 464
24. R.L. Benza, H.E. Grenett, R.C. Bourge Gene polymorphisms for plasminogen activator inhibitor-1/tissue plasminogen activator and development of allograft coronary artery disease Circulation 98 1998 2248 2254
25. C.A. Labarrere, D. Pitts, D.R. Nelson, W.P. Faulk Vascular tissue plasminogen activator and the development of coronary artery disease in heart-transplant recipients N Engl J Med 333 1995 1111 1116
26. C.A. Labarrere, D.R. Nelson, K.L. Spear Non-immunologic vascular failure of the transplanted heart J Heart Lung Transplant 22 2003 236 240
27. M.H. Yamani, R.C. Starling, J.B. Young Acute vascular rejection is associated with up-regulation of vitronectin receptor (alphavbeta3), increased expression of tissue factor, and activation of the extracellular matrix metalloproteinase induction system J Heart Lung Transplant 21 2002 983 989
28. M. Yousufuddin, D.J. Cook, R.C. Starling Angiotensin II receptors from peritransplantation through first-year post-transplantation and the risk of transplant coronary artery disease JAMA 43 2004 1565 1573
29. H.O. Ventura, M.R. Mehra C-reactive protein and cardiac allograft vasculopathy. Is inflammation the critical link? JAMA 42 2003 483 485
30. S.C. Stoica, M. Goddard, S.R. Large The endothelium in clinical cardiac transplantation Ann Thorac Surg 73 2002 1002 1008
31. M.S. Eisenberg, H.J. Chen, M.K. Warshofsky Elevated levels of plasma C-reactive protein are associated with decreased graft survival in cardiac transplant recipients Circulation 102 2000 2100 2104
32. K. Pethig, B. Heublein, I. Kutschka, A. Haverich Systemic inflammatory response in cardiac allograft vasculopathy high-sensitive C-reactive protein is associated with progressive luminal obstruction Circulation 102 suppl 3 2000 III-233 III-236
33. C.A. Labarrere, J.B. Lee, D.R. Nelson C-reactive protein, arterial endothelial activation, and development of transplant coronary artery disease a prospective study Lancet 360 2002 1462 1467
34. A. Hognestad, K. Endresen, R. Wergeland Plasma C-reactive protein as a marker of cardiac allograft vasculopathy in heart transplant recipients JAMA 42 2003 477 482
35. M.H. Park, P.A. Uber, R.L. Scott, M.R. Mehra B-type natriuretic peptide in heart transplantation an important marker of allograft performance Heart Fail Rev 8 2003 359 363
36. M.G. Buckley, M.H. Yacoub, D.R. Singer Investigation of the plasma concentrations and circulating forms of BNP and ANP in orthotopic cardiac transplant recipients J Hum Hypertens 12 1998 825 826
37. A. Ationu, N.D. Carter Molecular forms of brain and atrial natriuretic peptides in transplanted human heart Br J Biomed Sci 51 1994 316 320
38. M.H. Park, R.L. Scott, P.A. Uber Usefulness of B-type natriuretic peptide levels in predicting hemodynamic perturbations after heart transplantation despite preserved left ventricular systolic function Am J Cardiol 90 2002 1326 1329
39. M.R. Mehra, P.A. Uber, S. Potluri Usefulness of an elevated B-type natriuretic peptide to predict allograft failure, cardiac allograft vasculopathy, and survival after heart transplantation Am J Cardiol 94 2004 454 458
40. M.R. Mehra, P.A. Uber, M.H. Park Molecular pathways of cardiac allograft dysfunction independent of acute cellular rejection J Am Coll Cardiol 43 suppl A 2004 1051
41. A. Wells, L.A. Turka The role of apoptosis in the induction and maintenance of tolerance Curr Opin Organ Transplant 6 2001 1 6
42. B.D. Brown, D. Lillicrap Dangerous liaisons the role of "danger" signals in the immune response to gene therapy Blood 100 4 2002 1133 1140
43. M.R. Awad, S. Webber, G. Boyle The effect of cytokine gene polymorphisms on pediatric heart allograft outcome J Heart Lung Transplant 20 2001 625 630
44. S. Borozdenkova, J. Smith, S. Marshall, M. Yacoub, M. Rose Identification of ICAM-1 polymorphism that is associated with protection from transplant associated vasculopathy after cardiac transplantation Hum Immunol 62 2001 247 255
45. K. Pethig, B. Heublein, A. Hoffmann ACE-gene polymorphism is associated with the development of allograft vascular disease in heart transplant recipients J Heart Lung Transplant 19 2000 1175 1182
46. C.C. Baan, A.H. Balk, C.T. Holweg Renal failure after clinical heart transplantation is associated with the TGF-beta 1 codon 10 gene polymorphism J Heart Lung Transplant 19 2000 866 872
47. A.N. Abdallah, P. Cucchi-Mouillot, N. Biteau Analysis of the polymorphism of the tumour necrosis factor (TNF) gene and promoter and of circulating TNF-alpha levels in heart-transplant patients suffering or not suffering from severe rejection Eur J Immunogenet 26 1999 249 255
48. H.X. Zheng, S.A. Webber, A. Zeevi The impact of pharmacogenomic factors on steroid dependency in pediatric heart transplant patients using logistic regression analysis Pediatr Transplant 8 2004 551 557
49. H. Zheng, S. Webber, A. Zeevi Tacrolimus dosing in pediatric heart transplant patients is related to CYP3A5 and MDR1 gene polymorphisms Am J Transplant 3 2003 477 483
50. P.A. Horwitz, E.J. Tsai, M.E. Putt Detection of cardiac allograft rejection and response to immunosuppressive therapy with peripheral blood gene expression Circulation 110 2004 3815 3821
51. M.C. Deng, M.R. Mehra, H.J. Eisen Cardiac allograft monitoring using a novel clinical algorithm based on peripheral leukocyte gene expression profiling Circulation 108 suppl 2003 1801
52. M.R. Mehra, J. Kobashigawa, S. Hunt Molecular testing and prediction of clinical outcome in heart transplantation a prospective multicenter trial J Heart Lung Transplant 23 suppl 2 2004 S106 192